Why the study?
Warfarin has a narrow therapeutic index where small concentration changes can cause serious side effects, making awareness of potential interactions with other drugs or foods essential.
Cohort (n=128,584)
Yes
Highlights the critical need for awareness regarding warfarin's interactions with drugs and foods due to its narrow therapeutic index.
Answers are grounded in this paper and cite their sources.
Supports clinician education on warfarin interactions; leaves open whether this reduces bleeding or thrombosis rates.
Warfarin is a commonly used anticoagulant medication that is prescribed to patients at risk of developing blood clots. However, warfarin has a narrow therapeutic index, meaning that small changes in its concentration can lead to serious side effects, such as bleeding or an increased risk of stroke. Therefore, it is essential for healthcare providers and patients to be aware of potential interactions between warfarin and other drugs or foods that can affect its effectiveness.
No takes yet. Share an insight, caveat, or question.
Alzahrani et al. (2022) conducted a cohort in Patients requiring anticoagulation (mitral stenosis, artificial or mechanical heart valve, or heart valve repair) (n=128,584). Warfarin and interacting drugs (e.g., cotrimoxazole, amiodarone) vs. Warfarin without interacting drugs was evaluated on Percentage of INR values above the therapeutic range.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: